Be curious Cannabis Europa is all about facilitating new ideas and helping you learn all you want to know about medical cannabis in Europe. No one is an expert in all areas of medical cannabis, but absorbing new knowledge about areas that you may be less familiar with can only be of benefit moving forward. So sit in on the emerging science panel and have your mind blown by the latest cannabinoid research. Become an expert on European implementation issues listening to Ian Dunt in conversation with representative from the European Parliament and European Medicines Agency. Learn how to create...

A crucial part of any medical cannabis programme is the patients. They often play a key role in convincing governments to implement such programmes through their advocacy, and their needs and concerns are of utmost importance when it comes to deciding what kind of programme to put in place. Delegates at Cannabis Europa will have the opportunity to hear from influential medical cannabis patients from across the British Isles, Europe, and beyond. These include Clark French, Multiple Sclerosis sufferer and founder of the United Patients Alliance in the UK, who will be chairing our Patient Stories Panel.  (Clark French, Source:...

One of the key challenges facing regulators and producers in implementing medical cannabis programmes in any jurisdiction is how to do so in a way that best promotes and protects public health.  Medical cannabis programmes come with their own unique set of public health issues to consider, more so, perhaps, than regulated recreational cannabis models. Potential pitfalls are abundant. There is, for example, the decades-old debate over whether medical cannabis should be available in a smokable form (as it is in many US States including California and Colorado) or whether it might be better to require patients to vaporise, eat, or...

European medical cannabis markets are not yet mature, and consumer trends are only beginning to emerge as product choice broadens. What can be learnt from the more mature markets that have been operating the other side of the Atlantic?   Roy Bingham, CEO and Co-founder of BDS Analytics weighs in. In North America, legal cannabis retail sales in 2017 were $9.2 billion. We project that they will grow to over $24 Billion by 2021. We are confident on our predictions for that growth because, despite US Federal prohibition, state laws have been passed that already pave the way. Cannabis is North...